A Pilot Study to Evaluate the Feasibility, Safety and Engraftment of Zinc Finger Nuclease (ZFN) CCR5 Modified CD34+ Hematopoietic Stem/Progenitor Cells (SB-728mR-HSPC) in HIV-1 (R5) Infected Patients

Investigator(s):
Ronald Mitsuyasu, M.D.;
Organization: 
UCLA
NCT Number: 
Disease Name: 
HIV
Disease Category: 
Trial Phases: 
Phase 1
Trial Status: 
Recruiting
Trial Contact: 

Maricela Gonzalez 
(310) 557-3729 
mmgonzalez@mednet.ucla.edu